Since human clinical trials are essentially nonexistent, the available data comes from anecdotal reports from the biohacking community
Journal Articles Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth ( Journal of Orthopaedic Research ) Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing ( Cell and Tissue Research ) Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway ( Scientific Research ) Stable Gastric Pentadecapeptide BPC 157 and Wound Healing ( Frontiers in Pharmacology ) Insulin-like growth factor 1 (IGF-1): a growth hormone ( Molecular Pathology ) MK-677, an Orally Active Growth Hormone Secretagogue, Reverses Diet-Induced Catabolism ( The Journal of Clinical Endocrinology & Metabolism ) Two-Month Treatment of Obese Subjects with the Oral Growth Hormone (GH) Secretagogue MK-677 Increases GH Secretion, Fat-Free Mass, and Energy Expenditure ( The Journal of Clinical Endocrinology & Metabolism ) Kisspeptin signalling and its roles in humans ( Singapore Med J ) Age-Related Changes of the Pineal Gland in Humans: A Digital Anatomo-Histological Morphometric Study on Autopsy Cases with Comparison to Predigital-Era Studies ( Medicina ) Huberman Lab Episodes Mentioned This transcript is currently under human review and may contain errors
Current investigations continue to assess how peptide-based compounds interact within multi-pathway signaling environments, including potential influences on coordinated cellular processes and system-level biological responses in controlled laboratory models
Anti-TNF- discontinuation in children with juvenile idiopathic arthritis (JIA) led to high disease relapse rates (8088%) [153], while gradual dose-lowering of etanercept in these patients is safe in maintaining remission [154]
One research team concluded that using BPC-157 may not be appropriate, particularly when undetected cancer cells might be present
